Roman Ivanov

1.2k total citations
91 papers, 749 citations indexed

About

Roman Ivanov is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Roman Ivanov has authored 91 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Immunology, 33 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Roman Ivanov's work include CAR-T cell therapy research (17 papers), Biosimilars and Bioanalytical Methods (15 papers) and Virus-based gene therapy research (11 papers). Roman Ivanov is often cited by papers focused on CAR-T cell therapy research (17 papers), Biosimilars and Bioanalytical Methods (15 papers) and Virus-based gene therapy research (11 papers). Roman Ivanov collaborates with scholars based in Russia, Belarus and United States. Roman Ivanov's co-authors include Vasiliy Reshetnikov, Samantha Hol, Anton Hagenbeek, Alexander Malogolovkin, Saskia B. Ebeling, Аlbert R. Muslimov, S B Ebeling, Jillian M. Carr, Stuart M. Pitson and Loretta Dorstyn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Roman Ivanov

84 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roman Ivanov Russia 15 306 240 183 112 99 91 749
Brendan Ha United States 6 281 0.9× 386 1.6× 91 0.5× 123 1.1× 70 0.7× 9 744
David W. LaFleur United States 17 531 1.7× 402 1.7× 355 1.9× 102 0.9× 52 0.5× 22 1.2k
Antony Symons United States 11 613 2.0× 323 1.3× 154 0.8× 108 1.0× 42 0.4× 16 891
Leander Meuris Belgium 10 189 0.6× 537 2.2× 106 0.6× 91 0.8× 54 0.5× 22 873
Enguerran Mouly France 11 286 0.9× 519 2.2× 173 0.9× 154 1.4× 37 0.4× 15 907
Till A. Röhn Switzerland 14 549 1.8× 271 1.1× 112 0.6× 39 0.3× 39 0.4× 20 860
Jr‐Wen Shui United States 19 641 2.1× 410 1.7× 278 1.5× 106 0.9× 41 0.4× 27 1.1k
Mariastefania Antica Croatia 16 516 1.7× 318 1.3× 162 0.9× 67 0.6× 21 0.2× 51 1.1k
Yu Nee Lee United States 20 809 2.6× 479 2.0× 134 0.7× 319 2.8× 65 0.7× 35 1.3k
René Hubert United States 10 195 0.6× 541 2.3× 192 1.0× 231 2.1× 80 0.8× 17 1.1k

Countries citing papers authored by Roman Ivanov

Since Specialization
Citations

This map shows the geographic impact of Roman Ivanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roman Ivanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roman Ivanov more than expected).

Fields of papers citing papers by Roman Ivanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roman Ivanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roman Ivanov. The network helps show where Roman Ivanov may publish in the future.

Co-authorship network of co-authors of Roman Ivanov

This figure shows the co-authorship network connecting the top 25 collaborators of Roman Ivanov. A scholar is included among the top collaborators of Roman Ivanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roman Ivanov. Roman Ivanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ivanov, Roman, et al.. (2025). A Convenient, Pd-Free Approach to the Synthesis of Risdiplam. Molecules. 30(16). 3375–3375.
2.
Ivanov, Roman, et al.. (2025). Pyrrolysine Aminoacyl-tRNA Synthetase as a Tool for Expanding the Genetic Code. International Journal of Molecular Sciences. 26(2). 539–539. 1 indexed citations
3.
Ivanov, Roman, et al.. (2025). Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future. International Journal of Molecular Sciences. 26(23). 11679–11679.
4.
Fiorentino, Francesco, Gianluca Sbardella, Rino Ragno, et al.. (2025). An Amazing 30-Year Journey around the DABO Family: A Medicinal Chemistry Lesson on a Versatile Class of Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 68(6). 5993–6026. 1 indexed citations
5.
Reshetnikov, Vasiliy, et al.. (2025). Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine. International Journal of Molecular Sciences. 26(12). 5617–5617.
6.
Rotili, Dante, et al.. (2025). 1,2,4-Oxadiazoles in medicinal chemistry: trends of the last years. European Journal of Medicinal Chemistry. 297. 117935–117935. 2 indexed citations
7.
8.
Zaborova, Olga V., et al.. (2024). Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Frontiers in Pharmacology. 15. 1466337–1466337. 13 indexed citations
9.
Gushchin, Vladimir А., Andrei E. Siniavin, Elena V. Shidlovskaya, et al.. (2024). Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models. Vaccines. 12(11). 1206–1206. 2 indexed citations
10.
Reshetnikov, Vasiliy, Ilya M. Terenin, Vladimir Yeremeev, et al.. (2024). Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis. International Journal of Molecular Sciences. 25(2). 888–888. 12 indexed citations
11.
Minskaia, Ekaterina, et al.. (2024). Senolytic Vaccines from the Central and Peripheral Tolerance Perspective. Vaccines. 12(12). 1389–1389. 1 indexed citations
12.
Gushchin, Vladimir А., Andrei E. Siniavin, Evgeny V. Usachev, et al.. (2024). Major Role of S-Glycoprotein in Providing Immunogenicity and Protective Immunity in mRNA Lipid Nanoparticle Vaccines Based on SARS-CoV-2 Structural Proteins. Vaccines. 12(4). 379–379. 2 indexed citations
13.
Ivanov, Roman, et al.. (2024). Current Progress in the Development of mRNA Vaccines Against Bacterial Infections. International Journal of Molecular Sciences. 25(23). 13139–13139. 7 indexed citations
14.
Muslimov, Аlbert R., et al.. (2023). Effects of Combinations of Untranslated-Region Sequences on Translation of mRNA. Biomolecules. 13(11). 1677–1677. 14 indexed citations
15.
Revtovich, Svetlana V., Vitalia V. Kulikova, Elena A. Morozova, et al.. (2023). Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity. International Journal of Molecular Sciences. 25(1). 96–96. 3 indexed citations
16.
Muslimov, Аlbert R., Valeriy Tereshchenko, Daniil Shevyrev, et al.. (2023). The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics. International Journal of Molecular Sciences. 24(19). 14820–14820. 27 indexed citations
17.
Golovin, Andrey V., Maxim Gureev, Mikhail V. Biryukov, et al.. (2023). Naphthyl-Substituted Indole and Pyrrole Carboxylic Acids as Effective Antibiotic Potentiators—Inhibitors of Bacterial Cystathionine γ-Lyase. International Journal of Molecular Sciences. 24(22). 16331–16331. 6 indexed citations
18.
Гершович, П. М., et al.. (2019). The Role of Checkpoint Inhibitors and Cytokines in Adoptive Cell-Based Cancer Immunotherapy with Genetically Modified T Cells. Biochemistry (Moscow). 84(7). 695–710. 7 indexed citations
19.
Vi, Mazurov, et al.. (2019). A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study. Rheumatology International. 39(9). 1537–1546. 8 indexed citations
20.
Malkova, N A, et al.. (2019). The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. 119(10). 100–100. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brendan Ha Breakdown of academic impact, for papers by David W. LaFleur Breakdown of academic impact, for papers by Antony Symons Breakdown of academic impact, for papers by Leander Meuris Breakdown of academic impact, for papers by Enguerran Mouly Breakdown of academic impact, for papers by Till A. Röhn Breakdown of academic impact, for papers by Jr‐Wen Shui Breakdown of academic impact, for papers by Mariastefania Antica Breakdown of academic impact, for papers by Yu Nee Lee Breakdown of academic impact, for papers by René Hubert
Rankless by CCL
2026